PHOTO / CHINA
Manufacturing base of pharmaceutical company Novo Nordisk in Tianjin
By Xinhua Published: Sep 25, 2022 07:57 PM
Staff members work at a workshop of Novo Nordisk (China) Pharmaceutical Co., Ltd. in Tianjin, north China, Sept. 22, 2022. (Xinhua/Li Ran)

Staff members work at a workshop of Novo Nordisk (China) Pharmaceutical Co., Ltd. in Tianjin, north China, Sept. 22, 2022. (Xinhua/Li Ran)



 
Staff members work at a workshop of Novo Nordisk (China) Pharmaceutical Co., Ltd. in Tianjin, north China, Sept. 22, 2022. (Xinhua/Li Ran)

Staff members work at a workshop of Novo Nordisk (China) Pharmaceutical Co., Ltd. in Tianjin, north China, Sept. 22, 2022. (Xinhua/Li Ran)



 
A staff member works at a workshop of Novo Nordisk (China) Pharmaceutical Co., Ltd. in Tianjin, north China, Sept. 22, 2022. (Xinhua/Li Ran)

A staff member works at a workshop of Novo Nordisk (China) Pharmaceutical Co., Ltd. in Tianjin, north China, Sept. 22, 2022. (Xinhua/Li Ran)



 
A staff member works at a lab of Novo Nordisk (China) Pharmaceutical Co., Ltd. in Tianjin, north China, Sept. 22, 2022. (Xinhua/Li Ran)

A staff member works at a lab of Novo Nordisk (China) Pharmaceutical Co., Ltd. in Tianjin, north China, Sept. 22, 2022. (Xinhua/Li Ran)



 
A production line of anti-diabetes injection is pictured at a workshop of Novo Nordisk (China) Pharmaceutical Co., Ltd. in Tianjin, north China, Sept. 22, 2022. (Xinhua/Li Ran)

A production line of anti-diabetes injection is pictured at a workshop of Novo Nordisk (China) Pharmaceutical Co., Ltd. in Tianjin, north China, Sept. 22, 2022. (Xinhua/Li Ran)